Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
2024 Standout
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease
2024 Standout
2 intermediate papers

Works of Ho-Sook Kim being referenced

A Phase I Study of <b><i>UGT1A1</i></b> *<b><i>28/</i></b>*<b><i>6</i></b> Genotype-Directed Dosing of Irinotecan (CPT-11) in Korean Patients with Metastatic Colorectal Cancer Receiving FOLFIRI
2014
LC–MS/MS for the simultaneous analysis of arachidonic acid and 32 related metabolites in human plasma: Basal plasma concentrations and aspirin-induced changes of eicosanoids
2012

Author Peers

Author Last Decade Papers Cites
Ho-Sook Kim 116 107 58 171 32 430
Quan Zhou 98 104 37 181 56 452
Aiji Miyashita 127 103 67 177 20 442
P. du Souich 87 54 30 108 31 394
Fabien Lamoureux 88 41 42 78 39 503
Yan Jin 119 73 60 163 20 503
Li Liu 108 81 42 156 27 389
Hiromi Fukushima‐Uesaka 129 225 43 245 16 483
Nobuyuki Murayama 117 178 43 132 16 479
Wim J. Tamminga 60 104 88 260 12 482
N S Oates 116 137 53 329 11 505

All Works

Loading papers...

Rankless by CCL
2026